Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy?
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy? ; volume:14 ; number:1 ; day:25 ; month:6 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (25.6.2024), 1-10, 12.2024
- Urheber
-
Uzun, Mehmet
Atag, Elif
Caliskan Yildirim, Eda
Keser, Murat
Semiz, Huseyin Salih
Unal, Olcun Umit
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-64492-9
- URN
-
urn:nbn:de:101:1-2409152117004.582616920568
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Uzun, Mehmet
- Atag, Elif
- Caliskan Yildirim, Eda
- Keser, Murat
- Semiz, Huseyin Salih
- Unal, Olcun Umit
- SpringerLink (Online service)
Ähnliche Objekte (12)
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Clinicopathological Characteristics of Breast Cancer Patients with HER-2 Low Expression Receiving Neoadjuvant Therapy
Heparin priming of EUS-FNA needles does not adversely affect tissue cytology or immunohistochemical staining
Simultaneous Casualty Admissions—Do they Affect Treatment in the Receiving Trauma Center?
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Clinicopathological Characteristics of Breast Cancer Patients with HER-2 Low Expression Receiving Neoadjuvant Therapy
Heparin priming of EUS-FNA needles does not adversely affect tissue cytology or immunohistochemical staining
Simultaneous Casualty Admissions—Do they Affect Treatment in the Receiving Trauma Center?
Infectious morbidity in pediatric patients receiving neoadjuvant chemotherapy for sarcoma
Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Values of apparent diffusion coefficient in pancreatic cancer patients receiving neoadjuvant therapy
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Clinicopathological Characteristics of Breast Cancer Patients with HER-2 Low Expression Receiving Neoadjuvant Therapy
Heparin priming of EUS-FNA needles does not adversely affect tissue cytology or immunohistochemical staining